Target Name: LOC105379314
NCBI ID: G105379314
Review Report on LOC105379314 Target / Biomarker Content of Review Report on LOC105379314 Target / Biomarker
LOC105379314
Other Name(s): LOC105379314 variant X2 | Uncharacterized LOC105379314, transcript variant X2 | uncharacterized LOC105379314

LOC105379314: A Potential Drug Target or Biomarker

LOC105379314 (LOC105379314 variant X2) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and muscle. It is a member of the same family of proteins as the heat shock protein (HSP) family , which is known for their ability to assist in the regulation of cellular temperature and stress responses.

LOC105379314 variant X2 is of particular interest as a potential drug target or biomarker due to its unique structure and expression pattern. The X2 variant of LOC105379314 is a 21-kDa protein that is expressed in the brain and other tissues of the body. It is highly conserved in sequence with other members of the HSP family, and its structure is similar to that of other HSPs.

One of the key features of LOC105379314 is its ability to interact with various cellular signaling pathways. For example, LOC105379314 has been shown to interact with the protein heat shock factor (HSF)1, which is a key regulator of the HSP70 gene family. This interaction suggests that LOC105379314 may play a role in the regulation of cellular temperature and stress responses, which could make it an attractive target for drugs that are designed to modulate these pathways.

Another potential mechanism by which LOC105379314 may be involved in cellular signaling is its role in the regulation of inflammation. LOC105379314 has been shown to interact with the protein nuclear factor kappa B (NF-kappa-B), which is a well-known regulator of inflammation. This interaction suggests that LOC105379314 may play a role in the regulation of inflammatory responses, which could make it an attractive target for drugs that are designed to inhibit inflammation.

In addition to its potential role in cellular signaling, LOC105379314 is also of interest as a potential biomarker. The expression of LOC105379314 is highly dependent on the expression level of its precursor protein, which is encoded by the LOC105379314 gene. This makes LOC105379314 a potential candidate for use as a biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

LOC105379314 has also been shown to be expressed in a variety of tissues and organs, including the brain, heart, liver, and muscle. This suggests that it may be a useful biomarker for tracking the effects of drugs on these tissues, which could be particularly important in the context of disease treatment. For example, if a drug is shown to be effective in treating a neurodegenerative disease, it may be useful to track the levels of LOC105379314 in the brain to determine if this drug is having the desired effect.

In conclusion, LOC105379314 (LOC105379314 variant X2) is a protein that is of particular interest as a potential drug target or biomarker due to its unique structure and expression pattern. Its ability to interact with various cellular signaling pathways and its role in the regulation of inflammation suggest that it may be a promising target for drugs that are designed to modulate these pathways. As a potential biomarker, LOC105379314 may be a useful tool for tracking the effects of drugs on a variety of tissues and organs.

Protein Name: Uncharacterized LOC105379314

The "LOC105379314 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105379314 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105379315 | LOC105379318 | LOC105379341 | LOC105379344 | LOC105379362 | LOC105379365 | LOC105379382 | LOC105379385 | LOC105379395 | LOC105379399 | LOC105379490 | LOC105379514 | LOC105379570 | LOC105379599 | LOC105379614 | LOC105379647 | LOC105379648 | LOC105379652 | LOC105379656 | LOC105379658 | LOC105379660 | LOC105379663 | LOC105379664 | LOC105379665 | LOC105379667 | LOC105379749 | LOC105379857 | LOC105447645 | LOC107983962 | LOC107983963 | LOC107983974 | LOC107983976 | LOC107983981 | LOC107983982 | LOC107983986 | LOC107984003 | LOC107984041 | LOC107984063 | LOC107984079 | LOC107984098 | LOC107984108 | LOC107984113 | LOC107984118 | LOC107984129 | LOC107984137 | LOC107984144 | LOC107984145 | LOC107984146 | LOC107984179 | LOC107984214 | LOC107984221 | LOC107984238 | LOC107984251 | LOC107984256 | LOC107984264 | LOC107984284 | LOC107984314 | LOC107984316 | LOC107984326 | LOC107984361 | LOC107984363 | LOC107984381 | LOC107984390 | LOC107984408 | LOC107984526 | LOC107984530 | LOC107984536 | LOC107984543 | LOC107984558 | LOC107984563 | LOC107984567 | LOC107984576 | LOC107984588 | LOC107984625 | LOC107984626 | LOC107984634 | LOC107984647 | LOC107984654 | LOC107984665 | LOC107984671 | LOC107984703 | LOC107984706 | LOC107984710 | LOC107984737 | LOC107984755 | LOC107984782 | LOC107984788 | LOC107984793 | LOC107984798 | LOC107984827 | LOC107984867 | LOC107984869 | LOC107984880 | LOC107984901 | LOC107984903 | LOC107984911 | LOC107984913 | LOC107984928 | LOC107984932 | LOC107984934